(Apr 4) Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN)through its wholly owned subsidiary, Regen BioPharma, Inc(Regan)., is  a biotechnology company focused on the development of regenerative medicine therapies and tools. The Company is specifically focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs.
The focus of Regen BioPharma, Inc. is to developing translational medicine platforms for the rapid commercialization of stem cell therapies and to advance intellectual property licensed from entities, institutions and universities that show promise towards fulfilling the purpose of increased quality of life. Regen BioPharma has reviewed more than 20,000 US issued patents covering stem cell related subject matter, created a shortlist of 30 promising technologies for rapid commercialization, and currently is in negotiations to license several of these.
The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human “safety and signal of efficacy” stage (Phase I/II clinical trials), followed by exit. Having assembled a core infrastructure specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a “superincubator” that within 1-2 years grows technologies from laboratory to an asset ready for spin-off or sale.
For More information , visit   www.regenbiopharma.com
Disclaimer: This Newsletter is a paid advertisement, not a recommendation or solicitation of an offer to Buy or Sell the securities. Megapennystockpick.com is owned and operated by PSR Agency LLC. Any reference to “we” or “our” refers to PSR Agency LLC. We are engaged in the business of marketing and advertising companies, and in some instances we may have been offered for monetary compensation for our promotional efforts. Any compensation received will be mentioned below. All the content in our email newsletter and the website is for information purpose only and should not be considered as an offer or solicitation of an offer to buy, hold or sell any securities. Neither the owner nor any of its members, directors and employees are licensed brokers. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of the companies profiled by megapennystockpick.com. None of the information provided herein the Newsletter or through this website constitutes a recommendation that any investment or trading strategy is suitable for any person.
This newsletter may contain forward-looking statements, which involves risks and uncertainities. Viewers of this newsleter also should understand that trading activity and stock prices in many cases may tend to increase during the period of advertising campaigns of the profiled companies and in many cases may tend to decrease thereafter.
Some of the content in this newsletter may contain forward-looking information within the meaning of Section 27A of the securities Act of 1993 and Section 21E of the securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this website that are not statements of historical fact should be considered forward-looking statements, including statements regarding expected continual growth of the company and the value of its securities. Statements of opinion and belief are those of the authors and/or editors of this website, and are based solely upon the information possessed by such authors and/or editors; no inference should be drawn that the authors or editors have any special or greater knowledge about the companies profiled or any particular expertise in the industries or markets in which the profiled companies compete.
Investing in Micro-Cap securities is highly speculative and carries an extremely high degree of risk. Never invest in any stock featured herein unless you can afford to lose your entire investment. Readers are urged to consult with independent financial advisors with respect to a possible investment in any company profiled herein. Readers should independently conduct basic due diligence which should include, but not be limited to, the company’s annual reports, quarterly reports, press releases, and regulatory filings.

At the time of publication, PSR Agency LLC. has been offered compensation for its promotional efforts of $500 by a Non-Affiliated third party to develop awareness of BMSN(We have not been compensated for profiling COHO). Compensation, when and if received, or even the promise of future compensation, can be regarded as a major conflict of interest in our ability to be unbiased regarding the company(s) discussed in our newsletter. Anyone viewing this newsletter must assume that the hiring party may own the shares of the profiled company of which they may plan to liquidate, Any liquidation of the shares may or may not negatively impact the share price. (All of this compensation is a major conflict of interest in our ability to be unbiased regarding the company(s) discussed in our newsletter. This communication should be viewed as a commercial advertisement only). Please note that we do not own any position in securities of the profiled company.

All the information discussed in this newsletter is provided from the public sources. megapennystockpick.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided. Past performance of profiled securities is not indicative of future results, and the decision to buy or sell any security that may be featured is done purely at the reader’s own risk